Item 8.01 Other Events On March 13, 2026, Xenon Pharmaceuticals Inc. announced the meeting, record date and certain other information relating to its 2026 annual meeting of shareholders pursuant to a filing submitted to the System for Electronic Document Analysis and Retrieval in Canada.
XENE Xenon Pharmaceuticals Inc. - 8-K
Accession
0001193125-26-1061448.019.01
Item 8.01 - Other Events
44 words
Item 9.01 - Financial Statements and Exhibits
61 words
Item 9.01 Financial Statements and Exhibits (d) Exhibits. Pursuant to the rules and regulations of the Securities and Exchange Commission, the attached exhibit is deemed to have been furnished to, but not filed with, the Securities and Exchange Commission: Exhibit Number Description 99.1 SEDAR+ filing submitted March 13, 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).